Khaled El-Adl
41PUBLICATIONS
42CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (41)
Sort by Publication Date:
|Mar 12, 2026
Pyrazole/pyrimidine derivatives endowed with azobenzenes as dual EGFRT790M and VEGFR-2 inhibitors: anticancer, docking, synthesis, design and ADMET assessments.Kurls E Anwer, Mohamed A Abdelgawad, Felemban Athary Abdulhaleem M
|Feb 20, 2026
Pyrazolo[3,4-d]pyrimidine derivatives as VEGFR-2 and EGFRT790M dual inhibitors: design, docking, ADMET, synthesis and anticancer evaluations.Nada A A M Aziz, Riham F George, Tamer Nasr
|Sep 12, 2025
A two-decade overview of oxadiazole derivatives as promising anticancer agents.Mo'men Salem, Khaled El-Adl, Ahmed El-Morsy
|Apr 02, 2025
Design, nanogel synthesis, anti-proliferative activity and in silico ADMET profile of pyrazoles and pyrimidines as topo-II inhibitors and DNA intercalators.Ahmed K B Aljohani, Sanadelaslam S A El-Hddad, Marwa Alsulaimany
|Mar 24, 2025
A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine-incorporating molecules.Hamada S Abulkhair, Khaled El-Adl
Pageof 7
Frequent Collaborators
11 joint publications
Hamada S Abulkhair
9 joint publications
Ibrahim H Eissa
3 joint publications
Hatem Hussein Bayoumi
3 joint publications
Nour E A Abd El-Sattar
3 joint publications
Mohammed A Dahab
3 joint publications
Riham F George
3 joint publications
Mohamed S Alesawy
2 joint publications
Hany E A Ahmed
2 joint publications
Walaa R Mahmoud
2 joint publications
Sanadelaslam S A El-Hddad